Ars Live: The rise of GLP-1 drugs: Insights and Unknowns

Description

Ars Technica Senior Health Reporter Dr. Beth Mole is joined by Dr. Daniel J Drucker, MD, FRCPC from the Lunenfeld Tanenbaum Research Institute for a discussion on the implications, insights, and unknowns around the proliferation and rapid adoption of GLP-1 drugs.

À voir aussi

New Glenn Catastrophe Aftermath: What's Next for the Space Industry? | Ars Live

Ars Technica · Technologie

Is the Artificial Intelligence Bubble About to Pop? | Ars Live

Ars Technica · Technologie

Tariff Advocacy and Tech: The Semiconductor Scramble | Ars Live

Ars Technica · Technologie

The Heat is On: Climate Science in a Rapidly Changing World | Ars Live

Ars Technica · Technologie

Red Planet Promises: Is NASA really going to Mars? | Ars Live

Ars Technica · Technologie

Ars Live: Bing Chat—Our First Encounter With Manipulative AI

Ars Technica · Technologie